1. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review
   Yasar Torres-Yaghi et al, 2021, Neuropsychiatric Disease and Treatment CrossRef
2. Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
   Dubravka Svob Strac et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
3. Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
   Weichui Zhang et al, 2024, Expert Opinion on Drug Safety CrossRef
4. Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia
   Howard A. Fink et al, 2020, Annals of Internal Medicine CrossRef
5. The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
   Chieh-Hsin Lin et al, 2019, Frontiers in Pharmacology CrossRef
6. Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders
   Anamaria Bogdan et al, 2020, Frontiers in Pharmacology CrossRef
7. Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis
   Kaili Chen et al, 2023, Frontiers in Aging Neuroscience CrossRef
8. Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer’s disease: a meta-analysis
   Haiyan Wang et al, 2024, European Journal of Medical Research CrossRef